255 related articles for article (PubMed ID: 6749604)
1. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
Eriksson LS; Persson A; Wahren J
Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
[TBL] [Abstract][Full Text] [Related]
2. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.
Egberts EH; Schomerus H; Hamster W; Jürgens P
Gastroenterology; 1985 Apr; 88(4):887-95. PubMed ID: 3882509
[TBL] [Abstract][Full Text] [Related]
3. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
[TBL] [Abstract][Full Text] [Related]
5. [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].
Egberts EH; Schomerus H; Hamster W; Jürgens P
Z Ernahrungswiss; 1986 Mar; 25(1):9-28. PubMed ID: 3524038
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.
Plauth M; Egberts EH; Hamster W; Török M; Müller PH; Brand O; Fürst P; Dölle W
J Hepatol; 1993 Mar; 17(3):308-14. PubMed ID: 8315258
[TBL] [Abstract][Full Text] [Related]
7. Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study.
Walker S; Götz R; Czygan P; Stiehl A; Lanzinger G; Sieg A; Raedsch R; Kommerell B
Digestion; 1982; 24(2):105-11. PubMed ID: 7128954
[TBL] [Abstract][Full Text] [Related]
8. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
[TBL] [Abstract][Full Text] [Related]
9. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
[TBL] [Abstract][Full Text] [Related]
10. The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy.
Herlong HF; Maddrey WC; Walser M
Ann Intern Med; 1980 Oct; 93(4):545-50. PubMed ID: 7001971
[TBL] [Abstract][Full Text] [Related]
11. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
[TBL] [Abstract][Full Text] [Related]
12. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
[TBL] [Abstract][Full Text] [Related]
13. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review.
Metcalfe EL; Avenell A; Fraser A
Clin Nutr; 2014 Dec; 33(6):958-65. PubMed ID: 24656171
[TBL] [Abstract][Full Text] [Related]
15. Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis.
Iwasa M; Matsumura K; Watanabe Y; Yamamoto M; Kaito M; Ikoma J; Gabazza EC; Takeda K; Adachi Y
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):733-7. PubMed ID: 12811303
[TBL] [Abstract][Full Text] [Related]
16. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
Ndraha S; Hasan I; Simadibrata M
Acta Med Indones; 2011 Jan; 43(1):18-22. PubMed ID: 21339541
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic significance of branched-chain keto and amino acids].
Schauder P
Internist (Berl); 1984 May; 25(5):313-9. PubMed ID: 6376411
[No Abstract] [Full Text] [Related]
18. Branched-chain amino acids for hepatic encephalopathy.
Als-Nielsen B; Koretz RL; Kjaergard LL; Gluud C
Cochrane Database Syst Rev; 2003; (2):CD001939. PubMed ID: 12804416
[TBL] [Abstract][Full Text] [Related]
19. Effect of branched chain amino acid-enriched amino acid solution on normalization of plasma amino acids in hepatic encephalopathy.
Liaw KY; Chang CN; Wei TC; Lin JK
Taiwan Yi Xue Hui Za Zhi; 1985 Mar; 84(3):331-8. PubMed ID: 3860605
[No Abstract] [Full Text] [Related]
20. Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?
Vergara M; Castro-Gutiérrez V; Rada G
Medwave; 2016 Dec; 16(Suppl5):e6795. PubMed ID: 28024140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
